Tag Archives: FDA

Providing a better online product health website

Posted on August 9, 2011 | 3 Comments

While the FDA continues to delay on implementing social media guidelines DTC marketers can do more, a hell of lot more, with their interactive strategies to make them more relevant to consumers. It starts with the realization that consumers are probably going to come your product website and that there is a hell of an opportunity to answer their questions and provide them with information THEY want in language they understand. But it doesn’t stop there. Continue reading →

→ 3 Comments

Posted in Health information online

Tagged Consumer, Facebook, FDA, Food and Drug Administration, Harvard Medical School, Health informatics, Mayo Clinic, Social media

Shortage of cancer drugs

Posted on August 8, 2011 | 2 Comments

Ezekiel J. Emanuel wrote an opt ed piece in this weekends Times about the shortage of cancer drugs.He says “Of the 34 generic cancer drugs on the market, as of this month, 14 were in short supply. Only the older but curative cancer drugs — drugs that can cost as little as $3 per dose — have become unavailable. Most of these drugs have no substitutes, but, crazy as it seems, in some cases these shortages are forcing doctors to use brand-name drugs at more than 100 times the cost.” The story is full of generalizations and does not address the real problem underlying problems of generic cancer drugs. Continue reading →

→ 2 Comments

Posted in FDA

Tagged Chemotherapy, Economic shortage, Ezekiel Emanuel, Ezekiel J. Emanuel, FDA, Food and Drug Administration, Health, Manufacturing

It’s not about online health information, it’s what consumers do with that information

Posted on July 26, 2011 | 5 Comments

There is a lot, and I mean a lot, of health information on the Internet. Unfortunately there is also a lot of bad health information on the Internet and consumers have to pretty much figure out for themselves which sites offer credible and good health information, that they can understand, and which ones are full of garbage. What we should be worried about however is not all the health information that’s out there but what decisions consumers are making with information in hand. Continue reading →

→ 5 Comments

Posted in in the news

Tagged FDA, Food and Drug Administration, Google, Health, Health care provider, Health informatics, Patient, Physician

What potential budget cuts at FDA mean for drug marketers

Posted on July 18, 2011 | 2 Comments

As reported in the New York Times this weekend our economy is anemic right now. However politicians driven by ideology seem bound and determined to cut spending and the FDA is sure to see it’s budget cut down at a time when they need more money to keep up with new media and marketing. not to mention the 900+ cancer drugs that are in development. What does this mean for drug makers ? Look up the word “slow” in the dictionary and print it for future reference. Continue reading →

→ 2 Comments

Posted in in the news

Tagged FDA, Food and Drug Administration, Health, Health care, Manhattan Research, New York Times, Pharmaceutical industry

Should pharma be on Facebook and what can Facebook do to make it easier for them to engage consumers ?

Posted on July 11, 2011 | 5 Comments

Next month pharmaceutical companies have to make choice if they want to use Facebook as a maketing tool. They have to allow posts on their branded pages, not use Facebook for branded pages or use Pharma Wall Developed by In Touch Solutions. What Facebook wants biopharma companies to do is join the current trend in marketing from strictly outbound marketing to inbound marketing. Here is what Facebook needs to do to get pharma on board with marketing on Facebook. Continue reading →

→ 5 Comments

Posted in in the news

Tagged AstraZeneca, Business, Facebook, FDA, Food and Drug Administration, Marketing, Pharmaceutical industry, Social media

FDA wants drug companies to enforce REMS with physicians but is this realistic ?

Posted on December 6, 2010 | 6 Comments

REMS. Risk evaluation and mitigation strategies are increasingly being used used on prescription drugs and the FDA wants drug companies to enforce physician compliance with REMS requirements by cutting off prescribing rights for medications that have the most restrictive REMS. Continue reading →